Evergreen Capital Management LLC lifted its holdings in shares of NICE Ltd. (NASDAQ:NICE – Free Report) by 40.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,308 shares of the technology company’s stock after acquiring an additional 5,520 shares during the period. Evergreen Capital Management LLC’s holdings in NICE were worth $3,320,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Allspring Global Investments Holdings LLC raised its stake in shares of NICE by 135.4% in the second quarter. Allspring Global Investments Holdings LLC now owns 186 shares of the technology company’s stock worth $32,000 after purchasing an additional 107 shares during the last quarter. Richardson Financial Services Inc. purchased a new stake in NICE in the 1st quarter valued at $39,000. Lindbrook Capital LLC lifted its stake in NICE by 46.3% during the 1st quarter. Lindbrook Capital LLC now owns 199 shares of the technology company’s stock valued at $52,000 after acquiring an additional 63 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of NICE by 72.1% in the 1st quarter. GAMMA Investing LLC now owns 210 shares of the technology company’s stock worth $55,000 after acquiring an additional 88 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in shares of NICE by 72.4% in the 1st quarter. UMB Bank n.a. now owns 219 shares of the technology company’s stock worth $57,000 after acquiring an additional 92 shares in the last quarter. Institutional investors and hedge funds own 63.34% of the company’s stock.
NICE Price Performance
NICE opened at $166.94 on Tuesday. The firm has a 50-day moving average price of $171.73 and a 200-day moving average price of $195.64. NICE Ltd. has a twelve month low of $149.54 and a twelve month high of $270.73. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $10.50 billion, a price-to-earnings ratio of 30.13, a PEG ratio of 1.31 and a beta of 1.04.
Analyst Ratings Changes
Several research analysts recently weighed in on NICE shares. Northland Securities cut their price target on shares of NICE from $305.00 to $275.00 and set an “outperform” rating on the stock in a report on Friday, August 16th. StockNews.com downgraded NICE from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 14th. Barclays decreased their price target on NICE from $320.00 to $286.00 and set an “overweight” rating for the company in a research report on Thursday, July 25th. Morgan Stanley cut their price objective on NICE from $290.00 to $240.00 and set an “overweight” rating on the stock in a research report on Friday, June 14th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $300.00 target price on shares of NICE in a research report on Friday, August 16th. Sixteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $269.64.
Check Out Our Latest Analysis on NICE
NICE Profile
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
See Also
- Five stocks we like better than NICE
- Financial Services Stocks Investing
- The Average 401k Balance by Age Explained
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Insider Buying Explained: What Investors Need to Know
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for NICE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NICE and related companies with MarketBeat.com's FREE daily email newsletter.